AHMAD TIJJANI GARBA

Mr. AHMAD TIJJANI GARBA

Computer Engineering, King Mongkut's University of Technology Thonburi, Bangkok, Krung Thep Maha Nakhon, Thailand
+1
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2025 in Human-Centric Intelligent Systems
Verified
Journal Article
Open access
PDF file
AHMAD TIJJANI GARBAAHMAD TIJJANI GARBA
AHMAD TIJJANI GARBA
HHHafsah Shuaibu Hamza
Hafsah Shuaibu Hamza
Breast cancer is a serious global health challenge, calling for the invention of a reliable and interpretable machine learning (ML) models for its early detection. The Wisconsin Breast Cancer (WBC), Wisconsin Diagnostic Breast Cancer (WDBC), and Coimbra datasets are the three publicly available datasets that were used to train the four-machine learning (ML) classification models which are compared in this study: Logistic Regression, Decision Trees, Random Forest, and CatBoost. These models’ computational efficiency was measured by fit and test times, and their precision, recall, accuracy, F1-score, and area under the receiver operating characteristic curve (AUC-ROC) were evaluated. To promote transparency for clinical adoption, feature-level analysis of the model’s predictions was captured through the use of Local Interpretable Model-Agnostic Explanations (LIME). The highest accuracy was achieved using logistic regression, which recorded precision and recall values of 0.97/0.95 (WDBC), 0.95/0.92 (WBC), and 0.85/0.78 (Coimbra), respectively, thereby exceeding other models in terms of efficiency and consistency. The Key factors that matched clinical expectations were identified by LIME, including BMI (Coimbra), clump thickness (WBC), and radius mean (WDBC). The present research builds on previous work by combining various datasets and interpretable methodologies to address ML black-box challenges in medical diagnostics. Future research should look into larger, multi-layered medical datasets and deep learning models to enhance classification accuracy.

14 April 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
AHMAD TIJJANI GARBAAHMAD TIJJANI GARBA
AHMAD TIJJANI GARBA
ABAminu Suleiman Bashir
Aminu Suleiman Bashir
WDWenze Du
Wenze Du
AIAhmed Mahmud Ibrahim
Ahmed Mahmud Ibrahim
HSHarisu Abdullahi Shehu
Harisu Abdullahi Shehu
Md. Haidar SharifMd. Haidar Sharif
Md. Haidar Sharif
This study presents the first dedicated bibliometric analysis of artificial intelligence (AI) and deep learning applications in pediatric radiology and medical imaging, mapping the intellectual structure of a rapidly evolving field. A total of 2688 articles and conference proceedings published between 2005 and 2025 were retrieved from the Web of Science Core Collection and analyzed using Bibliometrix R and VOSviewer. The findings reveal exponential growth in publications, from 7 papers in 2005 to 559 in 2025, with journal articles dominating the corpus (85.9%). The most-cited contributions, led by Kermany et al. (2018) with 2886 citations, are predominantly technical feasibility studies rather than clinical outcome trials, indicating a field that has advanced methodologically but remains in early stages of clinical translation. Thematic mapping identifies convolutional neural networks, pneumonia, and transfer learning as Motor Themes representing methodological maturity in chest imaging, while neuroimaging and image segmentation clusters occupy Niche Themes, reflecting insular development with limited cross-field connectivity. Geographic analysis reveals concentrated co-authorship along US–China and US–Europe corridors, with African, Latin American, and Southeast Asian institutions largely absent from knowledge production networks. Eight of the ten most productive affiliations are North American, highlighting structural inequities that risk producing AI tools optimized for high-resource settings rather than the global pediatric population. This analysis provides an empirical foundation for reorienting the field toward clinical validation, geographic inclusion, and methodological integration across isolated research communities.

19 October 2026 in Frontiers in Artificial Intelligence
Verified
Journal Article
Open access
PDF file
ASAminu Bashir Suleiman
Aminu Bashir Suleiman
AHMAD TIJJANI GARBAAHMAD TIJJANI GARBA
AHMAD TIJJANI GARBA
AAAisha Mustapha Ahmad
Aisha Mustapha Ahmad
KMKaloma Usman Majikumna
Kaloma Usman Majikumna
HSHarisu Abdullahi Shehu
Harisu Abdullahi Shehu
HKHuseyin Kusetogullari
Huseyin Kusetogullari
Introduction: Artificial intelligence has been widely applied to chronic kidney disease (CKD), but the term ‘prediction” is frequently used for tasks ranging from contemporaneous disease classification to genuine forecasting of future renal outcomes. This systematic review examined this distinction while evaluating methodological quality and evidence for clinical translation. Methods: A predefined Scopus-based search covering 2021–2026 identified eligible AI- and machine-learning-based CKD studies. After screening and duplicate reconciliation, 169 unique primary studies were included. Future-oriented prediction required an identifiable baseline, predictors available at or before baseline, a subsequent renal outcome, and a meaningful prediction horizon. Studies were evaluated for modeling approaches, datasets, validation, calibration, explainability, clinical usefulness, and methodological quality using PROBAST+AI. Results: Of 169 studies, 122 (72.2%) addressed current-state CKD detection or classification, while only 46 (27.2%) contained a clearly future-oriented prediction component. Seventeen studies used geographic or institutional external validation and only four used an independent external cohort or dataset. Calibration was assessed in 12 studies and explicit explainability methods were reported in 16. PROBAST+AI identified high overall risk of bias in 156 studies during development and 164 during evaluation, with no study achieving an overall low-risk judgement. Discussion: CKD-AI evidence is substantially stronger for retrospective classification than for genuine early prediction or clinical translation. Future research should prioritize longitudinal prediction, independent and temporal validation, leakage-resistant analysis, calibration, clinically validated explainability, and prospective real-world evaluation.